These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10082495)

  • 1. Chronic bradykinin infusion and receptor blockade in angiotensin II hypertension in rats.
    Pasquié JL; Herizi A; Jover B; Mimran A
    Hypertension; 1999 Mar; 33(3):830-4. PubMed ID: 10082495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of chronic bradykinin infusion on angiotensin II hypertension in rats].
    Pasquié JL; Herizi A; Jover B; du Cailar G; Mimran A
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1035-8. PubMed ID: 9749160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats.
    Lima CV; Paula RD; Resende FL; Khosla MC; Santos RA
    Hypertension; 1997 Sep; 30(3 Pt 2):542-8. PubMed ID: 9322979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade.
    Herizi A; Jover B; Bouriquet N; Mimran A
    Hypertension; 1998 Jan; 31(1):10-4. PubMed ID: 9449383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretic response to acute hypertension is blunted during angiotensin II clamp.
    Leong PK; Zhang Y; Yang LE; Holstein-Rathlou NH; McDonough AA
    Am J Physiol Regul Integr Comp Physiol; 2002 Oct; 283(4):R837-42. PubMed ID: 12228052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
    Gohlke P; Pees C; Unger T
    Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-induced hypertension in bradykinin B2 receptor knockout mice.
    Cervenka L; Maly J; Karasová L; Simová M; Vítko S; Hellerová S; Heller J; El-Dahr SS
    Hypertension; 2001 Mar; 37(3):967-73. PubMed ID: 11270390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats.
    Tanaka Y; Nagai M; Date T; Okada T; Abe Y; Seki S; Taniguchi M; Taniguchi I; Mochizuki S
    Hypertens Res; 2004 Nov; 27(11):865-75. PubMed ID: 15824469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effect of enalapril in renovascular and angiotensin II hypertension.
    Herizi A; Demeilliers B; Jover B; Mimran A
    Clin Exp Hypertens; 1997; 19(5-6):953-64. PubMed ID: 9247767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension alters the endothelial-dependent biphasic response of bradykinin in isolated Microminipig basilar artery.
    Zahorul Islam M; Kawaguchi H; Miura N; Miyoshi N; Yamazaki-Himeno E; Shiraishi M; Miyamoto A; Tanimoto A
    Microvasc Res; 2017 Nov; 114():52-57. PubMed ID: 28587989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension.
    Stevenson KM; Edgley AJ; Bergström G; Worthy K; Kett MM; Anderson WP
    Hypertension; 2000 Nov; 36(5):839-44. PubMed ID: 11082153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inhibition of bradykinin B2-receptors enhances the slow vasopressor response to angiotensin II.
    Madeddu P; Parpaglia PP; Demontis MP; Varoni MV; Fattaccio MC; Glorioso N
    Hypertension; 1994 May; 23(5):646-52. PubMed ID: 8175175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
    Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
    Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats.
    Abbas A; Gorelik G; Carbini LA; Scicli AG
    Hypertension; 1997 Aug; 30(2 Pt 1):217-21. PubMed ID: 9260983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.
    Cloutier F; Ongali B; Campos MM; Thibault G; Neugebauer W; Couture R
    Br J Pharmacol; 2004 May; 142(2):285-96. PubMed ID: 15066903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II and bradykinin: interactions between two centrally active peptides.
    Lewis RE; Hoffman WE; Phillips MI
    Am J Physiol; 1983 Feb; 244(2):R285-91. PubMed ID: 6337513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats.
    Campbell DJ; Kelly DJ; Wilkinson-Berka JL; Cooper ME; Skinner SL
    Kidney Int; 1999 Jul; 56(1):211-21. PubMed ID: 10411695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM; Burrell LM; Kladis A; Campbell DJ
    J Card Fail; 1997 Mar; 3(1):41-52. PubMed ID: 9110254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.